Corvus Pharmaceuticals In... (CRVS)
3.64
-0.02 (-0.55%)
At close: Apr 25, 2025, 9:35 AM
13F Institute Ownership
Total Institutes of 101 in Corvus Pharmaceuticals expanded their positions with an increase of 29 investors compared to the previous quarter. An additional 7.64M shares, as total invested capital grew by $42.95M with ownership percentage increasing from 45.03% to 56.48%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.424
0.42
Call Flow 2,754,000
70%
Put Flow 1,166,500
30%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 10.41% | 6.94M | +0.00% | 37.15M | 0.77% |
| Samlyn Capital, LLC | 10.00% | 6.67M | +47.17% | 35.67M | 0.54% |
| Adams Street Partners LLC | 4.91% | 3.28M | +0.00% | 17.52M | 15.53% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.